Phantom GI
PrivateLast Round
Seed
Oct 8, 2026
Total Funding Raised
$5M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Phantom GI is a medical device company that develops minimally invasive percutaneous solutions for ostomy creation.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Phantom GI Comparables
Compare Phantom GI with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cook Group Incorporated | 71% | |
| CoapTech | 67% | |
| Eocene Ltd. | 66% |
For institutional investors. Book with your work email.
Phantom GI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 8, 2026 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Phantom GI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Innovation Authority | Grant |
| RUNI Ventures | Seed |
| Pitango Venture Capital | Seed |
| RAD BioMed | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 8, 2026
$5M round led by Pitango Venture Capital
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- is_developingOct 19, 2026
As of Oct 19th '26, Phantom GI, based in Israel, is developing PercStoma as a minimally invasive alternative to traditional ostomy surgery for bowel-obstruction patients who may be ineligible for surgery; the device is in preclinical studies, with clinical cases planned for early 2027.
- is_developingOct 19, 2026
Phantom GI is developing the PercStoma device as a minimally invasive alternative to traditional ostomy surgery, currently conducting a preclinical study and planning clinical cases for early 2027.
- is_developingOct 8, 2026
Phantom GI is developing its PercStoma device to create an ostomy under local anesthesia for bowel obstruction patients who cannot undergo conventional surgery, and plans to begin first-phase U.S. clinical studies, in Israel on Oct 8th '26.
- receives_financingOct 8, 2026
On Oct 8th '26, Phantom GI completes a $5M Seed round led by Pitango HealthTech, with RAD Biomed and RUNI Ventures participating, in Israel.
For institutional investors. Book with your work email.
Phantom GI Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Phantom GI's valuation, stock price, and market status.
Is Phantom GI a public or private company?
Phantom GI is a private company.
What is the current stock price of Phantom GI?
Phantom GI is a private company, so its shares have no public market price. Caplight tracks Phantom GI's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Phantom GI worth (valuation)?
Valuation information for Phantom GI is not publicly available.
Can I buy Phantom GI stock?
Phantom GI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Phantom GI's last funding round?
Phantom GI's most recent funding round was Seed on October 8, 2026.
Who are the main investors in Phantom GI?
Key investors in Phantom GI include Pitango Venture Capital.
Will Phantom GI IPO soon?
No public IPO plans have been announced for Phantom GI.
How can I track Phantom GI secondary market activity?
Caplight tracks bids, offers, and trades in Phantom GI's shares on secondary markets.